Skip to content
Home/Companies/Biotech/Callio Therapeutics
CT

Callio Therapeutics

Biotech·US·Active·1yr hold

Callio Therapeutics is a healthcare company, headquartered in France.

Entry
2025
Hold
1yr
Status
Active
Est. EV
–

Who owns Callio Therapeutics?

Callio Therapeutics is currently owned by Jeito Capital through Jeito II (2026 vintage), since 2025.

Hand-verified · updated 2026-04-21

Jeito Capital
Investor
Jeito Capital
Jeito II · 2026 · VC

Key facts

HQFrance
SectorHealthcare

More from Jeito II

Other portfolio companies in the same fund.

Adcendo
Active
BiotechDenmark· 2026
Alveus Therapeutics
Active
BiotechUS· 2026
Augustine Therapeutics
Active
BiotechBelgium· 2025
Azafaros
Active
BiotechNetherlands· 2025
Odyssey Therapeutics
Active
BiotechUS· 2025
Aviceda Therapeutics
Active
BiotechUS· 2024

More PE-backed in Biotech

Comparable biotech deals from other GPs.

GenSight Biologics
Active
Sofinnova PartnersFrance
InBrain Pharma
Active
Finovam GestionFrance
Isavy Biotech
Active
Ring CapitalFrance
NeoVacs
Active
Odyssée VentureFrance
ReNeuron Group
Exited 2024
Obotritia CapitalUnited Kingdom
Univercells
Exited 2023
AdBio PartnersBelgium
to
Data refreshed weekly · Sourced from public filings